To investigate the correlation between tumor/breast volume ratios measured by magnetic resonance imaging (MRI) and the surgical methods of breast cancer patients.
Methods:
Randomly collected 30 patients with breast conserving surgery as the study group and 30 patients undergoing modified radical mastectomy as the control group. There were 58 cases of si
ngle breast cancer and 2 cases of multiple breast cancer. All patients were selected for breast conserving or modified radical resection after a combination of routine examination
surgeon evaluation
and patient wishes. In each of the two groups
20 patients did not receive neoadjuvant chemotherapy before surgery and 10 patients received neoadjuvant chemotherapy before surgery. All patients underwent MRI examination before operation. Their tumor/mammary volume ratio was calculated retrospectively
and the difference of tumor/breast volume ratio was compared between the two groups.
Results:
In the study group
only 1 patient (3.33%) had positive incisal margin and underwent augmentation mass resection. The mean tumor/breast volume ratio of all patients in the study group and the control group was 4.35% and 9.65% (
P
=0.003). The average tumor/breast volume ratio of the two groups without preoperative neoadjuvant chemotherapy was 5.32% and 10.18% (
P
=0.027). The average tumor/breast volume ratios of preoperative neoadjuvant chemotherapy patients in the two groups were respectively 2.43% and 8.58% (
P
=0.07).
Conclusion:
The tumor/breast volume ratio measured from breast MRI data is related to the selection of surgical methods for newly diagnosed breastcancer patients
and it is an effective evaluation method to determine the optimal operation type of newly diagnosed breast cancer patients. However
the selection of surgical methods for patients undergoing neoadjuvant chemotherapy before surgery has not shown effective application value. In daily work
comprehensive assessment should be based on actual conditions.
Prediction of sentinel lymph node metastasis in breast cancer using multiparametric MRI radiomics and machine learning models
The progress of breast MRI in evaluating breast conservation therapy and ipsilateral breast tumor recurrence
Prediction value of breast MRI in ipsilateral breast tumor recurrence after breast-conserving surgery and distant metastasis following secondary surgery
The value of magnetic resonance imaging features in predicting 21-gene recurrence score of ER + /HER2 - breast
Development of a nomogram for differentiation between pure mucinous breast carcinomas and fibroadenomas based on DCE-MRI features
Related Author
Hongkai YANG
Xuan QI
Wuling WANG
Weiqun CHENG
Dong QI
Yongsheng HE
LI Jinhui
YOU Chao
Related Institution
Department of Radiology, Ma’anshan People’s Hospital, Ma’anshan
The Graduate School, Anhui Medical University
The Fifth Clinical Medical College of Anhui Medical University
Department of Radiology, Fudan University Cancer Center, Department of Oncology, Shanghai Medical College, Fudan University
Department of Breast Surgery, Fudan University Cancer Center, Department of Oncology, Shanghai Medical College, Fudan University